Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
531681 AMERISE

Amerise Biosciences Share Price

 

 

Amerise Biosciences live price: ₹0.71. It opened at ₹1 vs previous close ₹1; intraday high/low: ₹1/₹1. The 50 & 200 DMA stand at ₹0.70/₹0.70.

Amerise Biosciences Performance

  • Today's Low
  • ₹1
  • Today's High
  • ₹1
  • 52 Week Low
  • ₹1
  • 52 Week High
  • ₹1
  • Open Price₹1
  • Previous Close₹1
  • Volume9,809
  • 50 DMA₹0.70
  • 100 DMA₹0.69
  • 200 DMA₹0.70

Amerise Biosciences Chart

Investment Returns

  • Over 1 Month + 4.41%
  • Over 3 Month + 1.43%
  • Over 6 Month + 14.52%
  • Over 1 Year -16.47%

Smart Investing Starts Here Start SIP with Amerise Biosciences for Steady Growth!

Invest Now

Amerise Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 227.6
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 5
  • P/B Ratio
  • 0.9
  • Average True Range
  • 0.02
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.01
  • RSI
  • 49.08
  • MFI
  • 43.23

Amerise Biosciences Financials

Amerise Biosciences Technicals

EMA & SMA

Current Price
₹0.71
0 (0%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹0.72
  • 50 Day
  • ₹0.70
  • 100 Day
  • ₹0.69
  • 200 Day
  • ₹0.70

Resistance and Support

0.7 Pivot Speed
  • R3 0.74
  • R2 0.72
  • R1 0.72
  • S1 0.70
  • S2 0.68
  • S3 0.68

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Amerise Biosciences has an operating revenue of Rs. 8.66 Cr. on a trailing 12-month basis. An annual revenue growth of 37% is outstanding, Pre-tax margin of 8% is okay, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Amerise Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-05 Audited Results
2026-02-02 Quarterly Results
2025-11-05 Quarterly Results
2025-07-24 Quarterly Results
2025-05-19 Audited Results

Amerise Biosciences Shareholding Pattern

0%
71.97%
28.03%

Amerise Biosciences FAQs

Amerise Biosciences share price is ₹0 As on 30 May, 2026 | 04:18

The Market Cap of Amerise Biosciences is ₹4.7 Cr As on 30 May, 2026 | 04:18

The P/E ratio of Amerise Biosciences is 227.6 As on 30 May, 2026 | 04:18

The PB ratio of Amerise Biosciences is 0.9 As on 30 May, 2026 | 04:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23